PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32390596-0	2020	Expression of FOXM1 and Aurora-A predicts prognosis and sorafenib efficacy in patients with hepatocellular carcinoma.	Sorafenib	56-65	aurora kinase A	Homo sapiens	24-32	
32390596-10	2020	Furthermore, the concomitant high expression of FOXM1 and Aurora-A predicted the worst OS of sorafenib-treated patients with HCC.	Sorafenib	93-102	aurora kinase A	Homo sapiens	58-66	
32390596-11	2020	CONCLUSIONS: The co-expression of FOXM1 and Aurora-A could be a reliable biomarker to predict the sorafenib response and prognosis of HCC patients.	Sorafenib	98-107	aurora kinase A	Homo sapiens	44-52